The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the gleason score of prostate cancer by a subjective blood flow grading scale

Urologia Internationalis

Volumn 87, Issue 2, 2011, Pages 165-170

  Zhao, Hong Wei ^a   Luo, Jun Hang ^a   Xu, Hui Xiong ^a,b   Wang, Dao Hu ^a   Lai, Ying Rong ^a   Chen, Mian Ni ^a   Lv, Jian Yao ^a   Xie, Xiao Yan ^a   Lu, Ming De ^a   Chen, Wei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Contrast enhanced transrectal ultrasound; Diagnosis; Gleason score; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD FLOW GRADING SCALE; CONTRAST ENHANCED TRANSRECTAL ULTRASONOGRAPHY; DIAGNOSTIC TEST; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; RATING SCALE; TASK PERFORMANCE; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; BLOOD FLOW VELOCITY; CONTRAST MEDIA; FALSE POSITIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATIC NEOPLASMS; ROC CURVE; TREATMENT OUTCOME; ULTRASONICS; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 81155160897     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000327988     Document Type: Article

References (18)

1. Heidenreich A, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, Schmid HP, van der Kwast TH, Wiegel T, Zattoni F: Guidelines on prostate cancer; in EAU Guidelines Board and Working Panels: EAU Guidelines. Arnhem, EAU Guidelines Office, 2010, p 9.
2. Pallwein L, Mitterberger M, Gradl J: Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr Opin Urol 2007; 17: 39-47. (Pubitemid 44901089)
3. Wink M, Frauscher F, Cosgrove D, Chapelon JY: Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 2008; 54: 982-992.
4. Bigler SA, Deering RE, Brawer MK: Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24: 220-226. (Pubitemid 23066603)
5. Wilson NM, Masoud AM, Barsoum HB, Refaat MM, Moustafa MI, Kamal TA: Correlation of power Doppler with microvessel density in assessing prostate needle biopsy. Clin Radiol 2004; 59: 946-950. (Pubitemid 39276937)
6. Roy C, Buy X, Lang H, Saussine C, Jacqmin D: Contrast enhanced color Doppler endorectal sonography of the prostate: Efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003; 170: 69-72. (Pubitemid 36734413)
7. Halpern EJ: Contrast-enhanced ultrasound imaging of prostate cancer. Rev Urol 2006; 8:S29-S37.
8. Volavsek M, Masera A, Ovcak Z: Incidental prostatic carcinoma. A predictive role of neoangiogenesis and comparison with other prognostic factors. Pathol Oncol Res 2000; 6: 191-196.
9. Halpern EJ, Ramey JR, Strup SE: Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 2005; 104: 2373-2383. (Pubitemid 41691558)
10. Mitterberger M, Aigner F, Pinggera GM: Contrast-enhanced colour Doppler-targeted prostate biopsy: Correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy. BJU Int 2010; 106: 1315-1318.
11. Halpern EJ, Strup SE: Using gray scale, color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 2000; 174: 623-627. (Pubitemid 30126236)
12. Hou AH, Swanson D, Barqawi AB: Modalities for imaging of prostate cancer. Adv Urol 2009: 818065.
13. Kay PA, Robb RA, Bostwick DG: Prostate cancer microvessels: A novel method for three-dimensional reconstruction and analysis. Prostate 1998; 37: 270-277. (Pubitemid 28524660)
14. Schneider M: SonoVue, a new ultrasound contrast agent. Eur Radiol 1999; 9:S347-S348.
15. Claudon M, Cosgrove D, Albrecht T: Guidelines and good clinical practice recommendations for the contrast enhanced ultrasound (CEUS) -update 2008. Ultraschall Med 2008; 29: 28-44.
16. Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P: Prognostic value of the Gleason score in prostate cancer. BJU Int 2002; 89: 538-542. (Pubitemid 34948295)
17. Louvar E, Littrup PJ, Goldstein A, Yu L, Sakr W, Grignon D: Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83: 135-140. (Pubitemid 28299639)
18. Mitterberger M, Pinggera GM, Horninger W, Bartsch G, Strasser H, Schäfer G, Brunner A, Halpern EJ, Gradl J, Pallwein L, Frauscher F: Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: Impact on Gleason score. J Urol 2007; 178: 464-468. (Pubitemid 47030488)